TY - JOUR
T1 - Validation and quality measurements for STS, EuroSCORE II and a regional risk model in Brazilian patients
AU - REPLICCAR Study Group
AU - Vilca Mejia, Omar Asdrúbal
AU - Borgomoni, Gabrielle Barbosa
AU - Zubelli, Jorge Passamani
AU - Palma Dallan, Luís Roberto
AU - Alberto Pomerantzeff, Pablo Maria
AU - Praça Oliveira, Marco Antonio
AU - Junior, Orlando Petrucci
AU - Gradim Tiveron, Marcos
AU - Arruda Nakazone, Marcelo
AU - Tineli, Rafael Ângelo
AU - Campagnucci, Valquíria Pelisser
AU - Rocha e Silva, Roberto
AU - Rodrigues, Alfredo José
AU - Gomes, Walter José
AU - Ferreira Lisboa, Luiz Augusto
AU - Jatene, Fábio Biscegli
N1 - Funding Information:
Funding was received from the Brazilian Ministry of Health, Secretary of Health for the State of São Paulo, São Paulo Research Foundation (FAPESP), National Council of Technological and Scientific Development, and PPSUS Program/2012 that allowed the development of this study within the Process FAPESP N2012/51229-5 to OAVM. http://www.fapesp.br/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. To the REPLICCAR Study Group: InCor/HCFMUSP (Daniella de Lima Pes and Debora Duarte Maziero). To partner hospitals and their collaborators: Beneficência Portuguesa of São Paulo (Alexandre G. Sousa, Flavia Cortez Colosimo and Gilmara Silveira da Silva); Santa Casa of Marília (Helton Bomfim); Santa Casa of São Paulo (Gabriel L Mitsumoto); The State University of Campinas–UNICAMP (Michele Santana); São José of Rio Preto Hospital (Mariana Pastor); Santa Casa of Piracicaba; São Paulo Federal University (Rita Simone Lopes Moreira); SOBAM Group; Hospital das Clínicas from the University of São Paulo at Ribeirão Preto; the São Paulo Sacramento Hospital. To the Informatics Division of the InCor/HCFMUSP–(Marcos Yamaguti).
Publisher Copyright:
© 2020 Mejia et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PY - 2020/9
Y1 - 2020/9
N2 - Objectives The objectives of this study were to describe a novel statewide registry for cardiac surgery in Brazil (REPLICCAR), to compare a regional risk model (SPScore) with EuroSCORE II and STS, and to understand where quality improvement and safety initiatives can be implemented. Methods A total of 11 sites in the state of São Paulo, Brazil, formed an online registry platform to capture information on risk factors and outcomes after cardiac surgery procedures for all consecutive patients. EuroSCORE II and STS values were calculated for each patient. An SPScore model was designed and compared with EuroSCORE II and STS to predict 30-day outcomes: death, reoperation, readmission, and any morbidity. Results A total of 5222 patients were enrolled in this study between November 2013 and December 2017. The observed 30-day mortality rate was 7.6%. Most patients were older, overweight, and classified as New York Heart Association (NYHA) functional class III; 14.5% of the patient population had a positive diagnosis of rheumatic heart disease, 10.9% had insulin-dependent diabetes, and 19 individuals had a positive diagnosis of Chagas disease. When evaluating the prediction performance, we found that SPScore outperformed EuroSCORE II and STS in the prediction of mortality (0.90 vs. 0.76 and 0.77), reoperation (0.84 vs. 0.60 and 0.56), readmission (0.84 vs. 0.55 and 0.51), and any morbidity (0.80 vs. 0.65 and 0.64), respectively (p<0.001). Conclusions The REPLICCAR registry might stimulate the creation of other cardiac surgery registries in developing countries, ultimately improving the regional quality of care provided to patients.
AB - Objectives The objectives of this study were to describe a novel statewide registry for cardiac surgery in Brazil (REPLICCAR), to compare a regional risk model (SPScore) with EuroSCORE II and STS, and to understand where quality improvement and safety initiatives can be implemented. Methods A total of 11 sites in the state of São Paulo, Brazil, formed an online registry platform to capture information on risk factors and outcomes after cardiac surgery procedures for all consecutive patients. EuroSCORE II and STS values were calculated for each patient. An SPScore model was designed and compared with EuroSCORE II and STS to predict 30-day outcomes: death, reoperation, readmission, and any morbidity. Results A total of 5222 patients were enrolled in this study between November 2013 and December 2017. The observed 30-day mortality rate was 7.6%. Most patients were older, overweight, and classified as New York Heart Association (NYHA) functional class III; 14.5% of the patient population had a positive diagnosis of rheumatic heart disease, 10.9% had insulin-dependent diabetes, and 19 individuals had a positive diagnosis of Chagas disease. When evaluating the prediction performance, we found that SPScore outperformed EuroSCORE II and STS in the prediction of mortality (0.90 vs. 0.76 and 0.77), reoperation (0.84 vs. 0.60 and 0.56), readmission (0.84 vs. 0.55 and 0.51), and any morbidity (0.80 vs. 0.65 and 0.64), respectively (p<0.001). Conclusions The REPLICCAR registry might stimulate the creation of other cardiac surgery registries in developing countries, ultimately improving the regional quality of care provided to patients.
UR - https://www.scopus.com/pages/publications/85090816728
U2 - 10.1371/journal.pone.0238737
DO - 10.1371/journal.pone.0238737
M3 - Article
C2 - 32911513
AN - SCOPUS:85090816728
SN - 1932-6203
VL - 15
JO - PLoS ONE
JF - PLoS ONE
IS - 9 September
M1 - e0238737
ER -